The once-promising pill for obesity is facing challenges in the FDA due to its psychiatric side-effects.
Acomplia: An uphill battle?
More in Uncategorized
Past Week
Past 6 Months
-
Medicine’s struggle for inclusivity
-
Medicine is not apolitical: Your vote dictates your ability to practice medicine
-
Real pain deserves real treatment
-
Venture-backed telemental health care companies are creating a new opioid epidemic
-
Elite access vs. public scrutiny: Medication disparities exposed
-
When the doctor’s office becomes a confession booth
-
Recent Posts
-
AI in American medicine [PODCAST]
-
Your A+ in anatomy and physiology won’t improve the American health care system
-
The impact of war trauma, the challenge of objectivity, and the power of therapy and storytelling in healing
-
The compassion crisis in U.S. health care
-
Navigating COVID: a journey from academic intensity to healing
-
A tribute to primary care [PODCAST]
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
